Overcoming Challenges in CAR T-cell Product CGMP Release

Mol Ther. 2016 May;24(5):845-6. doi: 10.1038/mt.2016.72.

Authors

Concetta Quintarelli^{1

2}, Franco Locatelli^{1

3}, Ignazio Caruana¹, Biagio De Angelis¹

Affiliations

¹ Department of Pediatric Haematology and Oncology, Laboratory of Cell and Gene Therapy for Pediatric Tumors, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
² Department of Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Naples, Italy.
³ Department of Pediatrics, Università di Pavia, Pavia, Italy.

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Humans
Immunotherapy, Adoptive
Neoplasms / therapy*
Receptors, Antigen, T-Cell / therapeutic use*
T-Lymphocytes / cytology*

Substances

Antineoplastic Agents
Receptors, Antigen, T-Cell